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RETROGRADE CORONARY VENOUS MYOCARDIAL CONTRAST 
ECHOCARDIOGRAPHY IN HUMANS: CAN CORONARY VENOUS 
R~TRO~N~US~ON DELIVER PHARM4COLOCIC AGENTS TO THE 
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To verify that coronary venous r~tro~~fuaio~ reaches 
affected myocard~um eve,) when the coronary arteries are 
obstructed and to determine the effective coronary venous 
perfusion 
myocardial 
ntrast echoc ts during 
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iLe RCE was performed by r~tro~~fus~o~ into the great 
cardiac vein (MY) of ?Oml agitated contrast agents with 
hazardously high (81~15mmHg) and low (43+_lOm 
long axis images of the LV were recorded and 
off-line into a 512x512 pixel matrix. My 
perfusions were evaluated by the enhanced gray level 
after retroinfusion into WV and antegr-ade injection into 
LAD. There were no adverse effects during retroinfusion. 
Retroinfusio esulted in confluent and transmural 
opacification hanced gray levels wore: 
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In concluslonb coronary venous rotr Vf3F 
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